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1 |  INTRODUCTION
Psychosocial stress is a risk factor for major chronic condi-
tions including obesity (Moore & Cunningham, 2012), Type 
2 diabetes (T2D; Demakakos, Pierce, & Hardy, 2010; Nyberg 
et al., 2014), and coronary heart disease (CHD; Kivimaki & 
Steptoe, 2018). The stress‐T2D relationship is not fully ex-
plained by behavioral factors (Demakakos et al., 2010; 
Hackett & Steptoe, 2017; Nyberg et al., 2014), suggesting that 
stress‐related biological dysfunction may also be relevant.
Dysregulated biological processes can be manifested as 
dysregulated (re)activity of the stress biomarkers—either 
raised elevated resting/basal levels or maladaptive responses 
to acute stress (McEwen, 1998). Stress responsivity can be ex-
amined using a laboratory stress testing design (Gerin, 2010). 
More specifically, in the laboratory, stress biomarkers can be 
measured before, during, and after acute stressful tasks that 
are hypothesized to emulate real‐life stressors. This research 
strategy enables the control of environmental confounders, 
such as noise and room temperature, and is typically focused 
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Abstract
People with Type 2 diabetes (T2D) show dysregulated inflammatory responses to 
acute stress, but the effect of sex on inflammatory responses in T2D remains unclear. 
The purpose of this study was to investigate differences in interleukin (IL)‐6 stress 
responses between older men and women with T2D. One hundred and twenty‐one 
people (76 men; mean age = 64.09, SD = 7.35, 45 women; mean age = 63.20, 
SD = 6.70) with doctor‐verified T2D took part in this laboratory‐based stress testing 
study. Participants carried out acute mental stress tasks, and blood was sampled at 
baseline, immediately poststress, 45 min poststress, and 75 min poststress to detect 
plasma IL‐6 concentrations. IL‐6 change scores were computed as the difference 
between the baseline measurement and the three time points poststress. Main effects 
and interactions were tested using mixed model analysis of covariance. We found a 
significant main effect of time on IL‐6 levels, and a significant Sex × Time interac-
tion. In adjusted analyses including the three change scores and all the covariates, the 
significant Sex × Time interaction was maintained; IL‐6 responses were greater in 
women at 45 and 75 min poststress compared with men, adjusting for age, body mass 
index, smoking, household income, glycated hemoglobin, oral antidiabetic medica-
tion, insulin/other injectable antidiabetic medication, depressive symptoms, and time 
of day of testing. Different inflammatory stress response pathways are present in 
men and women with T2D, with women producing larger IL‐6 increases. The long‐
term implications of these differences need to be elucidated in future studies.
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on dynamic changes in biomarkers from pre‐ to poststress 
that could not be detectable if single measures were taken 
(Gerin, 2010).
The immune system is typically involved with the acute 
stress response (Chrousos, 1998), and a considerable number 
of studies have examined inflammatory stress responses that 
are known to reflect the activation of the innate immune sys-
tem (Marsland, Walsh, Lockwood, & John‐Henderson, 2017; 
Steptoe, Hamer, & Chida, 2007). The circulating proinflam-
matory cytokine interleukin (IL)‐6 is one of the most fre-
quently measured markers in laboratory studies (Marsland 
et al., 2017). IL‐6 is produced from a number of cell types 
after stimulation by the proinflammatory cytokine IL‐1β, 
and in turn stimulates the synthesis of the acute phase C‐ 
reactive protein (CRP) by hepatocytes (Steptoe et al., 2007). 
Results from two meta‐analyses showed that laboratory stress 
testing induces reliable increases in plasma IL‐6 (Marsland 
et al., 2017; Steptoe et al., 2007). Increases can be detectable 
in blood circulation as early as 10 min after stress and reach a 
peak around 90 min poststress (Marsland et al., 2017).
A very prominent feature of inflammatory stress re-
sponsivity is the large variability in the magnitude of stress 
responses between individuals. For example, increasing ev-
idence from basic and clinical research shows that sex, as 
a fundamental biological factor and an intrinsic individual 
characteristic, is relevant to shaping the acute stress response. 
A 2017 review of animal studies demonstrated consistent 
differences in biological responses to acute stress between 
male and female subjects (Novais, Monteiro, Roque, Correia‐
Neves, & Sousa, 2017). Human studies involving relatively 
healthy middle‐ or older‐aged participants also suggest 
marked sex differences in the magnitude of IL‐6 responses. 
In particular, three previous studies have provided evidence 
for women being more inflammatory responsive than men 
following laboratory stress. Specifically, women showed 
greater IL‐6 increases from baseline (prestress) to 30 min 
(Lockwood, Marsland, Cohen, & Gianaros, 2016), 45 min 
(Endrighi, Hamer, & Steptoe, 2016; Steptoe, Owen, Kunz‐
Ebrecht, & Mohamed‐Ali, 2002), and 75 min (Endrighi et al., 
2016) following stress (poststress).
Increased IL‐6 responsivity might be health damaging, 
conferring elevated risk for inflammatory‐related condi-
tions. Albeit scarce, there is evidence that individuals who 
show increased IL‐6 responses in the laboratory are prone 
to developing cardiovascular disease (CVD) risk factors in 
the long term outside the laboratory environment. For exam-
ple, in the study of Brydon and Steptoe (2005) of healthy 
middle‐aged participants, greater IL‐6 stress responses pre-
dicted larger increases in ambulatory systolic blood pressure 
3 years later. Results were adjusted for baseline ambulatory 
blood pressure, acute blood pressure stress responses, age, 
sex, body mass index (BMI), and smoking. Moreover, hostil-
ity has been related to larger IL‐6 stress responses in people 
with T2D, indicating an association between unfavorable per-
sonality characteristics and more pronounced IL‐6 increases 
poststress (Hackett, Lazzarino, Carvalho, Hamer, & Steptoe, 
2015). Finally, a recent study found that larger IL‐6 responses 
to acute stress in the laboratory are associated with higher 
levels of systemic inflammation in men, measured by rest-
ing CRP, possibly conferring higher risk for inflammatory‐ 
related diseases (Lockwood et al., 2016).
T2D is a chronic metabolic disease prevalent in more than 3 
million people in the UK (Holman, Young, & Gadsby, 2015). 
T2D has been characterized by physiological dysregulation 
across multiple biological systems, along with chronic life 
stress (Steptoe et al., 2014). For example, the IL‐6 profile of 
people with established T2D differs significantly from that of 
healthy individuals. In a 2013 meta‐analysis, a dose‐response 
relationship between IL‐6 and risk of new onset T2D was ob-
served (Wang et al., 2013), suggesting that inflammatory dys-
regulation exists prior to diabetes diagnosis. Epidemiological 
evidence indicated that people with T2D have elevated basal 
IL‐6 concentrations compared to healthy controls (Pickup, 
2004). In the laboratory environment, people with T2D have 
been found to have significantly higher plasma IL‐6 levels 
both pre‐ and poststress and showed smaller IL‐6 increases 
after stress compared to healthy controls. Therefore, despite 
diminished IL‐6 responses, absolute levels remained higher 
in the diabetes group (Steptoe et al., 2014). CVD is a major 
complication of T2D (Rao Kondapally Seshasai et al., 2011; 
Sarwar et al., 2010), and raised IL‐6 levels in established 
T2D have been associated with CVD risk and mortality, inde-
pendently of other inflammatory markers such as fibrinogen 
or CRP (Lowe et al., 2014).
Given that IL‐6 is adversely involved in T2D and its related 
complications, sex differences in IL‐6 stress responsivity 
may reflect different degrees of susceptibility to T2D devel-
opment and progression. Notably, before the age of the meno-
pause, the incidence of T2D and atherosclerosis is higher in 
men compared with women, while after the menopause these 
conditions in women equal or exceed the rates observed in 
same‐aged men (Gubbels Bupp, 2015). Moreover, the im-
pact of psychosocial stress on T2D risk is greater in women 
than in men (Kautzky‐Willer, Harreiter, & Pacini, 2016), and 
some inflammatory‐mediated conditions are more prevalent 
in women with T2D compared with their male counterparts, 
including CHD, stroke, kidney disease, fibromyalgia, depres-
sion, and vascular dementia (Anderson, Freedland, Clouse, & 
Lustman, 2001; Chatterjee et al., 2016; Kautzky‐Willer et al., 
2016; Peters, Huxley, & Woodward, 2014a, 2014b; Yanmaz, 
Mert, & Korkmaz, 2012). The mechanisms that underpin 
these differences are likely, to some extent, the result of sex 
differences in stress‐related biology. Better understanding 
of the potentially protective effects of one sex could help 
to develop preventive and management strategies for both 
sexes.
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To the best of our knowledge, no previous studies have 
examined sex differences in inflammatory stress responses 
in people with T2D. The aim of this study was to extend 
previous research in stress‐related biology between men and 
women with T2D. The objective of this study was to inves-
tigate potential differences in IL‐6 stress responses between 
older men and women with T2D. We hypothesized that 
women with T2D will show greater IL‐6 stress responses 
compared with men with T2D.
2 |  METHOD
2.1 | Study sample
One hundred and forty people (88 men, 52 women) aged 
50–75 years with doctor‐verified T2D diagnosis took part in a 
laboratory‐based stress testing study. This was part of a larger 
trial comparing biological responses to laboratory stress be-
tween healthy individuals and people with T2D, and full details 
of the sample can be found elsewhere (Steptoe et al., 2014). 
In order to detect small to moderate effect sizes (δ = 0.32, 
p < 0.05), we aimed to recruit at least 125 people. Participants 
were recruited from diabetes outpatient clinics and primary 
care practices in London between March 2011 and July 2012. 
Inclusion was limited to people without a history or previous 
diagnosis of CHD, inflammatory diseases, allergies, or mood 
disorders, and no evidence of autonomic neuropathy based on 
self‐report. Obesity is one of the main risk factors for diabetes 
(Guh et al., 2009); therefore, it was not possible to exclude obese 
individuals from this study. All participants gave fully informed 
written consent to take part in the study, and ethical approval 
was obtained by the UK National Research Ethics Service.
Out of 140 participants, 34 had missing data for at least 
one IL‐6 measurement owing to issues in blood sampling and 
analysis. More precisely, as the majority of participants were 
obese, maintaining a functioning cannula for the duration of 
the laboratory session presented technical challenges; the can-
nula failed partway through the laboratory procedure for some 
participants. We had a protocol to not reattempt blood draw in 
this case so as to minimize distress for participants. A sensitiv-
ity analysis was also carried out to check for significant differ-
ences in participants’ characteristics between those with full 
data on IL‐6 and those with missing data on at least one IL‐6 
measurement using t tests for continuous and chi‐square for 
categorical variables. This analysis revealed that participants 
of higher BMI were more likely to have missing data on at least 
one IL‐6 measurement (p = 0.017), but there were no other dif-
ferences between those with and without missing data on IL‐6.
2.2 | Procedure
Participants were invited for individual stress testing in our 
light‐ and temperature‐controlled laboratory at University 
College London (UCL). Testing was performed in either the 
morning or afternoon and was based on a standard protocol 
previously used in the same laboratory (Hamer, O’Donnell, 
Lahiri, & Steptoe, 2010; Steptoe, Owen et al., 2002). 
Pretesting instructions included to avoid taking any anti‐in-
flammatory or antihistamine medication up to 7 days before 
testing session, to refrain from performing vigorous exercise 
and consuming alcohol from the evening prior to testing, and 
to avoid caffeinated beverages or smoking for at least 2 hr 
before testing. Participants who reported colds or other infec-
tions on the day of testing were rescheduled.
On the testing day, participants’ anthropometric char-
acteristics (height, weight, waist, hip, percentage of body 
fat) were first assessed using standardized techniques. 
Following this, a venous cannula was inserted into partici-
pants’ forearm for blood sample collection. Within the last 
5 min of a 30‐min resting phase, a blood sample was drawn 
to detect baseline IL‐6 levels. We then administered two 
5‐min mental stress tasks, and blood was sampled again 
immediately after the tasks (immediately post‐task mea-
surement), at 45 min (45 min post‐task measurement), and 
at 75 min after the completion of the tasks (75 min post‐
task measurements). Blood samples were collected using 
ethylenediaminetetraacetic acid (EDTA) tubes (four tubes 
for each participant), which were centrifuged immediately 
after collection at 2,500 rpm for 10 min at room tempera-
ture. Ten minutes later, plasma was removed from the tubes, 
aliquoted into 0.5‐ml portions, and stored at −80°C until 
batch analysis at a later date. For batch analysis, we used 
Quantikine high sensitivity two‐site enzyme‐linked immu-
nosorbent assay (ELISA) from R&D Systems (Oxford, UK). 
IL‐6 sensitivity ranged between 0.016 and 0.110 pg/ml, 
and the mean intra‐assay and interassay coefficients of 
variations were 7.3% and 7.7%, respectively.
2.3 | Mental stress tasks
Two 5‐min mental stress tasks were administered in ran-
dom order: a computerized version of the Stroop color‐
word interference task and the mirror tracing task. The 
Stroop task requires successive reporting of target color 
words (e.g., blue, red) presented (on a screen) in an incon-
gruous color. The mirror tracing task requires participants 
to move a metal stylus to trace a star while looking at the 
mirror image. When the stylus comes off the star’s outer 
line, a loud noise is emitted by the device and a mistake is 
counted (Lafayette Instruments Company, Lafayette, IN). 
We told participants that the average person achieves five 
tracings with a minimum of mistakes in the time given. 
These tasks are used widely in experimental studies as they 
induce robust biological stress responses, and they have 
been used in previous studies by our group (Hamer et al., 
2010; Steptoe, Feldman et al., 2002).
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2.4 | Study measures
2.4.1 | Predictor variable
Sex
Self‐reported information on sex was obtained, categorized 
into man/woman.
2.4.2 | Dependent variable
IL‐6 stress responses
Plasma IL‐6 concentrations were measured at four time 
points: baseline, immediately post‐task, 45 min post‐task, and 
75 min post‐task. Three IL‐6 mean change/delta (Δ) scores 
were used as dependent variables, reflecting the mean differ-
ence/change in IL‐6 from baseline to post‐task measurement: 
immediately post‐task minus baseline (ΔIL‐6 immediately 
post‐task), 45 min post‐task minus baseline (ΔIL‐6 45 min), 
and 75 min post‐task minus baseline (ΔIL‐6 75 min). Higher 
positive delta scores indicated greater IL‐6 increases from 
baseline to post‐task measurements.
2.4.3 | Covariates
We selected a number of covariates based on previous re-
search that has indicated their influence on inflammatory 
(re)activity: age (Steptoe, Owen et al., 2002), BMI (kg/m2; 
McInnis et al., 2014), smoking status (smoker/nonsmoker; 
Marsland et al., 2017), household income (<£20,000/£20,00
0 – £40,000/£40,000 – £60,000/> £60,000) as an indicator of 
socioeconomic status (Steptoe, Owen et al., 2002; Stringhini 
et al., 2013), and depressive symptoms (Howren, Lamkin, & 
Suls, 2009). Presence of a health condition (healthy vs. having 
a clinical condition) is known to influence inflammatory stress 
responses (Steptoe et al., 2007); thus, glycated hemoglobin 
(HbA1c) and antidiabetic medication (oral medication/insulin 
or other injectable medication) at the time of testing were also 
selected as these could reflect different levels of disease sever-
ity. IL‐6 shows some diurnal variation with increasing levels 
over the course of the day (Vgontzas et al., 2005); therefore, 
time of testing (am/pm) was also included in the models.
Age, smoking status, and household income were re-
corded by self‐report, and BMI was calculated from height 
and weight measurements on the day of testing. Antidiabetic 
medication was also recorded by self‐report and confirmed 
by inspection of medication packaging on the day of test-
ing. HbA1c was assessed from the baseline blood draw 
using standardized techniques. For depressive symptoms, 
participants completed the Centre of Epidemiological 
Studies–Depression (CES‐D) scale (Radloff, 1977). This is 
a standardized questionnaire consisting of 20 items relating 
to depressive symptoms over the previous week. Responses 
can range from 0 (rarely or none of the time/less than 1 day) 
to 3 (most or all the time/5–7 days). Responses were summed 
with higher scores indicating greater depressive symptoms 
over the previous week. The Cronbach’s alpha was satisfac-
tory in this sample (0.86).
2.4.4 | Other measures
Other variables considered in secondary analyses were eth-
nicity (white/Asian/Afro‐Caribbean/other), educational level 
(no qualifications or elementary school diploma/up to O lev-
els or middle or junior high school diploma/A levels–ONC or 
high school or senior high school diploma/degree, or univer-
sity undergraduate certificate or above), marital status (mar-
ried/single/separated, or divorced or widowed), and hours 
of moderate or vigorous physical activity per week were 
recorded based on self‐report. Further adiposity measures 
were also recorded: percentage of body fat and waist‐to‐hip 
ratio. Adiposity measures were calculated from measure-
ments taken on the testing day. Cardiovascular medication 
at the time of testing was also recorded by self‐report and 
confirmed by inspection of medication packaging on the day 
of testing. Categories of cardiovascular medication included 
antihypertensive medication (yes/no), beta‐blockers (yes/no), 
cholesterol‐lowering drugs (yes/no), and aspirin (yes/no).
Baseline subjective stress and task perception variables 
were also measured in this study. Baseline subjective stress 
was measured before the tasks by asking participants, “How 
stressed do you feel at the moment?” Participants answered on 
a 7‐point scale, with higher scores indicating greater baseline 
subjective stress. After each of the stress tasks, participants 
were asked to rate how stressful the task was using a 7‐point 
scale (1 = not at all stressful, 7 = very stressful). Moreover, 
ratings of task involvement, task control, task performance, 
and task difficulty were also taken after each of the tasks, 
with responses on a 7‐point scale (1 = not at all involved, 
in control, well, difficult; 7 = very involved, in control, well, 
difficult). Responses for the two tasks were averaged to create 
overall scores for task perceptions. Higher scores indicated 
higher stress, higher involvement, higher control, better per-
formance, and greater difficulty, respectively.
2.5 | Statistical analysis
IL‐6 values were skewed, thus log‐n transformation was used 
in all analyses except values presented in Table 1 for ease of 
interpretation. Characteristics of men and women were com-
pared with chi‐square for categorical and t tests for continu-
ous variables.
Significant main effects and interactions were first tested 
using mixed model analysis of variance (ANOVA). IL‐6 values 
were analyzed across four time points: baseline, immediately 
post‐task, 45 min post‐task, and 75 min post‐task, with sex 
being the between‐subjects factor and the four time points the 
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T A B L E  1  Sample characteristics by sex
Characteristic Men (n = 76) Women (n = 45) pa
Age, M (SD) years 64.09 (7.35) 63.20 (6.70) 0.506
Marital status, n (%) 0.070
Married 45 (59.2) 17 (37.8)
Single 13 (17.1) 13 (28.9)
Divorced, separated, or widowed 18 (23.7) 15 (33.3)
Household income, n (%) 0.060
<£20,000 31 (40.8) 21 (46.7)
£20,000–£40,000 17 (22.4) 17 (37.8)
£40,000–£60,000 8 (10.5) 3 (6.7)
> £60,000 20 (26.3) 4 (8.9)
Ethnicity, n (%) 0.021
White 61 (80.3) 35 (77.8)
Asian 10 (13.2) 1 (2.2)
Afro‐Caribbean 4 (5.3) 4 (8.9)
Other 1 (1.3) 5 (11.1)
Educational level, n (%)b 0.726
No qualifications (elementary school diploma) 5 (6.8) 3 (6.7)
Up to O levels (middle or junior high school diploma) 16 (21.6) 6 (13.3)
A levels/ONC (high school or senior high school diploma) 7 (9.5) 5 (11.1)
Degree (university undergraduate certificate) or above 46 (62.2) 31 (68.9)
Smoking, n (%) smoker 11 (14.5) 5 (11.1) 0.803
Moderate/vigorous physical activity, M (SD) hours/weekc 4.08 (8.19) 3.89 (4.18) 0.889
BMI, M (SD) kg/m2 30.11 (5.13) 32.14 (6.33) 0.057
Body fat, M (SD) % 30.96 (4.58) 44.32 (6.94) <0.001
Waist‐to‐hip ratio, M (SD) cmd 1.01 (0.07) 0.97 (0.11) 0.050
HbA1c, M (SD) % 7.28 (1.36) 7.38 (1.64) 0.700
Oral antidiabetic medication, n (%) yes 62 (81.6) 38 (84.4) 0.878
Insulin/other injectable diabetic medication, n (%) yes 9 (11.8) 6 (13.3) 1.000
Antihypertensive medication, n (%) yes 55 (72.4) 30 (66.7) 0.647
Beta‐blockers, n (%) yes 7 (9.2) 4 (8.9) 1.000
Cholesterol‐lowering drugs, n (%) yes 57 (75.0%) 37 (82.2) 0.486
Aspirin, n (%) yes 33 (43.4) 9 (20.0) 0.016
CES‐D scale, M (SD) 11.60 (8.19) 11.84 (8.28) 0.875
Baseline subjective stress, M (SD) 1.45 (0.82) 1.58 (1.01) 0.441
Task stress, M (SD) 4.25 (1.50) 5.00 (1.33) 0.006
Task involvement, M (SD) 5.24 (1.52) 5.66 (1.59) 0.153
Task control, M (SD) 2.50 (1.21) 2.43 (1.47) 0.798
Task performance, M (SD) 2.23 (1.17) 2.13 (1.31) 0.674
Task difficulty, M (SD) 5.63 (1.07) 5.99 (1.00) 0.074
Baseline IL‐6 (unlogged values; pg/mL)e 2.19 (1.29) 2.01 (1.31) 0.459
IL‐6 immediately post‐task (unlogged values; pg/mL)f 2.21 (1.22) 2.14 (1.38) 0.785
IL‐6 45 min post‐task (unlogged values; pg/mL)g 2.32 (1.41) 2.33 (1.59) 0.972
IL‐6 75 min post‐task (unlogged values; pg/mL)h 2.30 (1.18) 2.26 (1.38) 0.873
AM (morning) testing, n (%) yes 32 (42.1) 21 (46.7) 0.765
Note. N = 121. AM = after midnight; BMI = body mass index; CES‐D = Centre for Epidemiological Studies–Depression; HbA1c = glycated hemoglobin; kg/m2 = 
kilogram/square meter; M = mean; N = number; n = number; ONC = Ordinary National Certificate; pg/mL = pictogram/millilitre; SD = standard deviation.
aDifferences by sex were checked using t tests for continuous variables and chi‐square tests for categorical variables. bn = 119. cn = 111. dn = 120. en = 116. fn = 112. 
gn = 101. hn = 93. 
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within‐subject factor. Significant interactions were further ex-
plored using mixed model analysis of covariance (ANCOVA). 
In this model, three IL‐6 mean change scores were used as de-
pendent variables (values were first logged and then calculated 
to change scores), reflecting the mean difference in IL‐6 from 
baseline to immediately post‐task (ΔIL‐6 immediately post‐
task), 45 min post‐task (ΔIL‐6 45 min), and 75 min post‐task 
(ΔIL‐6 75 min). Higher positive delta scores indicate greater 
IL‐6 increases from baseline to post‐task measurements. To 
avoid overadjustment, only nine covariates were included: age, 
BMI, smoking status, household income, HbA1c, oral antidia-
betic medication, insulin/other injectable antidiabetic medica-
tion, depressive symptoms, and time of testing. Change scores 
account for baseline levels; therefore, the three change scores 
rather than the four time points were used as dependent vari-
ables in the main analysis. Secondary analyses were carried 
out to control for potential confounders using mixed model 
ANCOVA. Moreover, secondary analyses were conducted to 
test for the effects of age on IL‐6 responsivity in women using 
mixed model and repeated measures ANOVA.
We analyzed data from 121 participants (76 men, 45 women) 
who provided data on sex and all covariates. Results in Table 1 
are presented as means and standard deviations (M ± SD) for 
continuous variables or n and per cent for categorical variables. 
The level of significance was set at p < 0.05, though exact p 
values are reported throughout. Statistical analyses were con-
ducted using SPSS version 24 (SPSS, Chicago, IL).
3 |  RESULTS
3.1 | Sample characteristics by sex
Table 1 presents sample characteristics by sex. There were 
no significant sex differences in age, marital status, income, 
or education. There was a sex difference in ethnicity, with 
more men than women being of South Asian origin, χ2(3) 
= 9.77, p = 0.021, V = 0.28. Participants were obese on 
 average. Women had significantly higher body fat percentage, 
t(66.977) = −11.51, p < 0.001, d = 2.27, 95% CI [−15.67, 
−11.04], while men had marginally higher waist‐to‐hip ratios, 
t(118) = 1.98, p = 0.050, d = 0.36, 95% CI [−0.00, 0.06]. Men 
and women did not differ in diabetes characteristics or lifestyle 
variables including HbA1c, antidiabetic medication, BMI, 
smoking, or physical activity, though men were more likely to 
take aspirin at the time of testing; χ2(1) = 5.85, p = 0.016, φ = 
−0.24. No other sex differences were found (Table 1).
3.2 | Sex differences in perceived 
tasks appraisals
Task ratings showed that women perceived the tasks as more 
stressful than men, t(188) = −2.78, p = 0.006, d = 0.53, 95% 
CI [−1.29, −0.22]. There were no significant sex differences 
in task difficulty, task involvement, task control, or task per-
formance (Table 1).
3.3 | Sex differences in IL‐6 stress responses
Plasma IL‐6 levels increased significantly over time (time 
effect, F(2.436, 219.279) = 13.18, p < 0.001, 휂2
p
 = 0.128), 
from baseline (x̄ = 0.53 ± 0.06) to 75 min (x̄ = 0.69 ± 0.06) 
poststress. There was also a significant Sex × Time interac-
tion, F(2.436, 219.279) = 5.39, p = 0.003, 휂2
p
 = 0.056 (Figure 
1), providing evidence of sex differences in IL‐6 stress 
responses.
The ANCOVA model including the three change scores 
as the within‐subject factor and sex as the between‐subjects 
factor revealed a significant Sex × Time interaction indicat-
ing that IL‐6 responses differed significantly between men 
and women after controlling for age, BMI, smoking, income, 
HbA1c, oral antidiabetic medication, insulin/other injectable 
antidiabetic medication, depressive symptoms, and time of 
testing, F(1.881, 152.384) = 4.19, p = 0.019, 휂2
p
 = 0.049. 
Significant differences between women and men occurred at 
45 min when women exhibited greater IL‐6 responses com-
pared with men (ΔIL6 45 min for women: x̄ = 0.17 ± 0.04 
vs. men: x̄ = 0.007 ± 0.03, p = 0.002, 95% CI [0.65, 0.27]), 
and this difference was sustained at 75 min responses (ΔIL6 
75 min for women: x̄ = 0.26 ± 0.06 vs. men: x̄ = 0.06 ± 0.04, 
p = 0.004, 95% CI [0.06, 0.34]). The adjusted IL‐6 stress re-
sponses are depicted in Figure 2.
Using a secondary model, analyses were carried out to 
control for the effects of body fat percentage, waist‐to‐hip 
ratio, aspirin intake, ethnicity, and stress perception, and the 
significant Sex × Time interaction was maintained, F(1.776, 
147.386) = 4.05, p = 0.023, 휂2
p
 = 0.047. Despite being not sta-
tistically significant, baseline IL‐6 levels were slightly higher 
for men than women (as reflected in Figure 1). Adjusting for 
baseline IL‐6 levels attenuated the Sex × Time interaction 
(p = 0.075).
We carried out additional analysis to test for the effects 
of age in the magnitude of IL‐6 stress responses in women. 
Within women, IL‐6 levels over time did not interact with age 
(p = 0.955). Examining IL‐6 levels over time separately for 
younger and older women (≤ 55/> 55) revealed a greater main 
effect of time for older women, F(3, 21) = 4.74, p = 0.011, 
versus younger women, F(2.083, 60.412) = 8.88, p < 0001.
4 |  DISCUSSION
We investigated sex differences in IL‐6 responses to labora-
tory stress in a sample of middle‐and older‐aged men and 
women with T2D. Although the mean IL‐6 values were 
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higher for men at baseline, this difference was not signifi-
cant. Female participants exhibited significantly larger IL‐6 
stress responses at 45 and 75 min post‐task compared to 
male participants. IL‐6 increases in women were detect-
able at 45 min post‐task, and continued to increase reaching 
the highest levels at 75 min post‐task. IL‐6 changes in men 
were more delayed, showing observable, albeit marginally 
significant increases at 75 min post‐task. Significant sex dif-
ferences in IL‐6 responses were independent of age, BMI, 
smoking status, household income, HbA1c, oral antidiabetic 
medication, insulin/other injectable antidiabetic medication, 
depressive symptoms, and time of testing. Secondary analy-
sis confirmed the Sex × Time interaction after controlling for 
body fat percentage, waist‐to‐hip ratio, aspirin intake, ethnic-
ity, and stress perception. These findings highlight different 
inflammatory response pathways to acute stress between men 
and women with T2D.
The lack of previous studies in people with T2D or pre-
diabetes does not permit direct comparisons with similar 
samples. Nevertheless, our findings are consistent with three 
previous studies on healthy middle‐ or older‐aged partic-
ipants, which demonstrated greater IL‐6 stress responses 
F I G U R E  1  Mean plasma IL‐6 values at four time points in men and women with T2D (n = 92). Values are unadjusted mean plasma IL‐6 
(logged n) at baseline, immediately post‐task, 45 min, and 75 min post‐task. Pairwise comparisons showed significant differences within women 
category at 45 and 75 min compared to baseline (45 min compared to baseline: p < 0.001, 95% CI [0.094, 0.249], 75 min compared to baseline: 
p < 0.001, 95% CI [0.140, 0.355]) and immediately post‐task values (45 min compared to immediately post‐task: p = 0.002, 95% CI [0.052, 0.216], 
75 min compared to immediately post‐task: p < 0.001, 95% CI [0.108, 0.311]). Marginally significant increases were observed within men category 
at 75 min compared to immediately post‐task (p = 0.087, 95% CI [−0.010, 0.142]) and 45 min values (p = 0.088, 95% CI [−0.008, 0.113]). There 
were no significant sex differences in baseline or post‐task IL‐6 values between women and men (checked with independent samples t tests). Error 
bars are standard errors of the mean. IL‐6 = interleukin 6; ln = log n
F I G U R E  2  Mean changes in plasma 
IL‐6 from baseline to three time points 
post‐task in men and women with T2D 
(n = 92). Results are adjusted for age, BMI, 
smoking status, household income, HbA1c, 
oral antidiabetic medication, insulin/other 
injectable drugs use, depression symptoms, 
and time of testing. Error bars are 
standard errors of the mean. ΔIL‐6 = delta 
interleukin‐6 (change score); ln = log n
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in women (Endrighi et al., 2016; Lockwood et al., 2016; 
Steptoe, Owen et al., 2002). On the contrary, null and con-
flicting findings have been reported in studies of younger 
participants (Edwards, Burns, Ring, & Carroll, 2006; 
Rohleder, Schommer, Hellhammer, Engel, & Kirschbaum, 
2001), although the smaller sample sizes in these studies (40 
and 45 participants, respectively) may have contributed to the 
inconsistent findings.
It is also plausible that lower levels of reproductive hor-
mones associated with ageing in women or menopausal 
status may explain the sex differences that are more consis-
tently found in older participants. In the study of Endrighi 
and colleagues (2016), circulating IL‐6 stress responses were 
greater in women compared to men, with all women being 
postmenopausal. Additionally, in the study of Prather and 
colleagues (2009), lipopolysaccharide‐stimulated IL‐6 pro-
duction was significantly greater in postmenopausal women 
at 30 min poststress compared with men and premenopausal 
women. Reproductive hormones may have contributed to 
sex differences found in our study. Estrogens, which are 
thought to have anti‐inflammatory effects, are reduced in 
ageing women (Winters, 2001), potentially having a permis-
sive effect on IL‐6 production and gene expression. We did 
not collect information on menopausal status in our study; 
therefore, it was not possible to directly test this hypothesis, 
though menopause usually occurs between 45 and 55 years 
of age and the mean age for a woman to reach the menopause 
in the UK is 51 (NHS, 2018). Mean age of the women in our 
sample was 63 years old (SD = 6.70). Only three out of the 
45 women in this study were ≤51 years old and eight of them 
were ≤55 years old. Thus, it is conceivable that the great ma-
jority of women in our sample were postmenopause. In our 
secondary analyses, we found a greater main effect of time on 
IL‐6 levels for older versus younger women. These findings 
lend support for the hypothesis that postmenopausal women 
may exhibit greater responses, but this needs testing directly 
in future studies.
Men and women in our study did not differ in key be-
havioral or clinical measures including smoking, physical 
activity, BMI, HbA1c, antidiabetic or cardiovascular medi-
cation. We found significant differences in aspirin use and 
body fat percentage, but including these factors in our sec-
ondary model did not attenuate the significant Sex × Time 
interaction effect. Women rated the tasks as more stressful 
than men, and it is possible that the effect of the stress tasks 
on participants’ mood was reflected in physiological acti-
vation. A laboratory‐based study with middle‐aged, healthy 
participants showed that task‐related increases in anxiety pre-
dicted increases in IL‐6 concentrations (Carroll et al., 2011). 
Nevertheless, including stress perception in our secondary 
model did not alter the significant Sex × Time interaction, 
and the Stress Perception × Time interaction was not signifi-
cant. In the recent meta‐analysis of Marsland et al. (2017), the 
magnitude of IL‐6 responsivity did not vary as a function of 
task type (social threat vs. other stressor), but analyses were 
not conducted separately for women and men. Therefore, it 
is possible that tasks different than those used in the current 
study could lead to different stress appraisals and/or different 
inflammatory activation patterns between men and women. 
Another possible explanation is that sex differences in physi-
ological reactivity reflect different levels of chronic life stress 
exposure between men and women with T2D. Depressive 
symptoms did not differ between men and women, though, 
and IL‐6 response differences were sustained despite inclu-
sion of depressive symptoms in the analyses. Furthermore, 
human studies on sex differences in cortisol responsivity 
(cortisol is a glucocorticoid [GC] and a known anti‐inflam-
matory factor primarily involved in the acute stress response 
[Nicolaides, Kyratzi, Lamprokostopoulou, Chrousos, & 
Charmandari, 2015]) would be informative, but results on 
sex differences in cortisol responsivity appear inconsis-
tent (Kudielka & Kirschbaum, 2005; Liu et al., 2017; Paris 
et al., 2010). Interestingly, there is evidence that the sensitiv-
ity of immune cells to the anti‐inflammatory effects of GCs 
increases 1 hr after acute stress only in men and not women 
(Rohleder et al., 2001). Nevertheless, it is not known how 
far these neuroendocrine and cellular sensitivity differences 
are generalized to people with diabetes. Stress‐related media-
tors, including IL‐6, cortisol, and catecholamines, act syner-
gistically to maintain homeostasis (Karatsoreos & McEwen, 
2010), and future studies need to examine how the interaction 
of these factors may influence sex differences in stress re-
sponsivity in people with T2D.
The clinical significance of heightened IL‐6 responses to 
stress remains unclear. In this study, although baseline sex 
differences in IL‐6 were not significant, IL‐6 was somewhat 
higher in men both at baseline and following stress. So, despite 
greater IL‐6 responses in women, female participants did not 
have greater IL‐6 concentrations than male participants over-
all. It is not certain whether the heightened stress responsivity 
of women or the higher absolute values among men is more 
hazardous to health. Interestingly, ageing women with T2D 
seem to be more vulnerable to psychosocial stress‐related 
factors and to inflammatory‐related clinical outcomes com-
pared with similarly aged men (Kautzky‐Willer et al., 2016). 
It is plausible that sex differences in acute stress responsiv-
ity account for these sex differences. In previous laboratory 
studies, larger inflammatory responses were prospectively 
associated with CVD risk factors (Brydon & Steptoe, 2005; 
Ellins et al., 2008; Steptoe, Kivimaki, Lowe, Rumley, & 
Hamer, 2016). Nevertheless, due to the lack of prospec-
tive studies linking stress responses with physical health 
outcomes in people with T2D, it is not yet known whether 
heightened IL‐6 responsivity to stress is health damaging in 
T2D, as observed in healthy samples, since endothelial dys-
function and biological dysregulation are already established 
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in this population (Ghiadoni et al., 2000; Steptoe et al., 2014). 
Studies investigating the longitudinal association between 
inflammatory stress responsivity and health outcomes in 
people with T2D are warranted. Finally, although the inflam-
matory response has been recognized as an integral part of 
the stress response (Chrousos, 1998; Marsland et al., 2017; 
Steptoe et al., 2007), IL‐6 is secreted from multiple sources, 
such as the liver (Heinrich, Castell, & Andus, 1990) or from 
muscle tissue during exercise (Petersen, 2012; Shephard, 
2002), and these responses are not part of the inflammatory 
response. However, increases in IL‐6 and other pro‐ or anti‐
inflammatory factors, such as monocyte chemoattractant pro-
tein (MCP)‐1 or IL‐1 receptor antagonist (IL‐1ra), have been 
reported in individual laboratory studies (Hackett, Hamer, 
Endrighi, Brydon, & Steptoe, 2012; Steptoe, Willemsen, 
Owen, Flower, & Mohamed‐Ali, 2001), suggesting a simul-
taneous upregulation of inflammatory factors, thus support-
ing the notion that IL‐6 activation represents changes within 
the inflammatory signaling cascade.
4.1 | Study strengths and limitations
To the best of our knowledge, this is the first study to exam-
ine sex differences in IL‐6 stress responses in people with 
T2D. This is a relatively large laboratory study. However, 
full biological data were collected for only about three quar-
ters of participants due to difficulties in blood sampling. 
We encountered practical challenges related to obesity dur-
ing the insertion of the cannula in some participants, and 
therefore we controlled for BMI in all our analyses. Despite 
having a relatively long post‐task blood sampling period, 
a more extended sampling would have provided additional 
detail, particularly in view of evidence that IL‐6 responses 
to stress may continue to increase beyond 75 min after the 
tasks (Marsland et al., 2017). We took into account a wide 
range of potential confounders, including sociodemographic, 
behavioral, clinical, and psychological factors. The sole 
focus on IL‐6 provides a limited perspective on sex differ-
ences in stress‐related changes in inflammatory functioning. 
Nevertheless, we recently showed that other inflammatory 
factors, including IL‐1ra and MCP‐1, do not increase in re-
sponse to acute stress in people with T2D, in contrast to IL‐6 
(Panagi, Poole, Hackett, & Steptoe, 2018), adding value to 
testing IL‐6 responsivity in people with T2D. Despite not 
being statistically significant, baseline IL‐6 levels were 
slightly higher for men than women. It is possible that ceil-
ing effects were involved in the change in IL‐6 over time 
for men. Indeed, adjustment for baseline IL‐6 in models at-
tenuated the Sex × Time interaction. This possibility needs 
to be investigated in future studies with a larger sample size. 
Given the differences between people with T2D and healthy 
individuals in IL‐6 (re)activity, a direct comparison between 
people with T2D and healthy people would be of interest in 
future work. The participants of this study were middle‐aged 
and older men and women with T2D and without a history of 
CHD. They were recruited from the London area, and most 
of them were of white European ethnicity, thus we do not 
know whether similar patterns would emerge among other 
cohorts.
In conclusion, women with T2D exhibit greater stress‐ 
induced increases in plasma IL‐6 than men, adjusting for 
covariates. The long‐term effects of these response patterns 
upon health need to be determined in future studies.
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